Abstract | BACKGROUND: METHODS: Type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats were randomized into an untreated diabetic group (n = 9) and a GW610742-treated diabetic group (n= 9). The GW610742 was administered (10 mg/kg/day) orally for 11 weeks. Long-Evans Tokushima Otsuka rats (n = 9) were used as a non-diabetic control. RESULTS:
Albuminuria was markedly increased and renal PPAR-δ expression was decreased in diabetes. Diabetic albuminuria and renal injury markers, such as glomerular basement membrane thickening, decreased number of slit pores between podocyte foot processes, decreased nephrin expression, increased desmin expression and increased CCL2 expression, were significantly reversed through the treatment with GW610742. PPAR-δ agonist GW610742 markedly increased nephrin expression in cultured podocytes. Nephrin mRNA expression was markedly decreased in response to high glucose in cultured podocytes and effectively prevented by GW610742. CONCLUSIONS:
|
Authors | Eun Young Lee, Geun Tae Kim, Miri Hyun, Suji Kim, Sujin Seok, Ran Choi, Mi Young Lee, Choon Hee Chung |
Journal | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
(Nephrol Dial Transplant)
Vol. 27
Issue 11
Pg. 4069-79
(Nov 2012)
ISSN: 1460-2385 [Electronic] England |
PMID | 22892126
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- GW 610742
- Membrane Proteins
- PPAR gamma
- Thiazoles
- nephrin
|
Topics |
- Albuminuria
(drug therapy, metabolism)
- Animals
- Blotting, Western
- Cell Culture Techniques
- Diabetes Mellitus, Type 2
(complications, drug therapy, metabolism)
- Diabetic Nephropathies
(drug therapy)
- Immunohistochemistry
- Membrane Proteins
(metabolism)
- PPAR gamma
(agonists)
- Podocytes
(drug effects, metabolism)
- Rats
- Rats, Inbred OLETF
- Real-Time Polymerase Chain Reaction
- Thiazoles
(pharmacology)
|